Crinetics Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Betz Stephen F. | Chief Scientific Officer | Option Exercise | 18,000 | $1.91 | $34,380 | Dec 26, 2025 |
| Struthers Richard Scott | President & CEO | Option Exercise | 16,342 | $9.28 | $151,654 | Dec 18, 2025 |
| Pizzuti Dana | Chief Med and Dev Officer | Option Exercise | 5,000 | $16.89 | $84,450 | Dec 1, 2025 |
| Pizzuti Dana | Chief Med and Dev Officer | Sale | 100 | $43.27 | $4,327 | Nov 3, 2025 |
| Pizzuti Dana | Chief Med and Dev Officer | Option Exercise | 5,000 | $16.89 | $84,450 | Oct 1, 2025 |
| Struthers Richard Scott | President & CEO | Sale | 4,000 | $45.00 | $180,000 | Sep 26, 2025 |
| Fust Matthew K | — | Option Exercise | 10,000 | $1.91 | $19,100 | Sep 26, 2025 |
| Pizzuti Dana | Chief Med and Dev Officer | Sale | 5,000 | $32.10 | $160,500 | Sep 2, 2025 |
| Pizzuti Dana | Chief Med and Dev Officer | Sale | 30,000 | $30.43 | $912,900 | Aug 22, 2025 |
| Pizzuti Dana | Chief Med and Dev Officer | Sale | 6,492 | $29.18 | $189,437 | Aug 20, 2025 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 97,483 | $32.23 | $3,141,877 | Jun 12, 2025 |
| Deardorf Caren | — | Award / Grant | 6,900 | — | — | Jun 11, 2025 |
| Vivaldi Coelho Rogerio | — | Award / Grant | 6,900 | — | — | Jun 11, 2025 |
| Okey Stephanie | — | Award / Grant | 6,900 | — | — | Jun 11, 2025 |
| Fust Matthew K | — | Award / Grant | 6,900 | — | — | Jun 11, 2025 |
| Bedrosian Camille L | — | Award / Grant | 6,900 | — | — | Jun 11, 2025 |
| Nichols Weston | — | Award / Grant | 6,900 | — | — | Jun 11, 2025 |
| WIERENGA WENDALL | — | Award / Grant | 6,900 | — | — | Jun 11, 2025 |
| Struthers Richard Scott | President & CEO | Gift | 90,400 | — | — | May 14, 2025 |
| Struthers Richard Scott | President & CEO | Option Exercise | 81,270 | $1.91 | $155,226 | Apr 2, 2025 |
| Pizzuti Dana | Chief Med and Dev Officer | Sale | 127 | $34.83 | $4,423 | Mar 19, 2025 |
| Knight Jeff E. | Chief Operating Officer | Sale | 6,801 | $34.17 | $232,390 | Mar 19, 2025 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 291 | $34.83 | $10,136 | Mar 19, 2025 |
| Struthers Richard Scott | President & CEO | Sale | 16,463 | $34.17 | $562,541 | Mar 19, 2025 |
| Schilke Tobin | Chief Financial Officer | Award / Grant | 52,000 | — | — | Mar 10, 2025 |
| Struthers Richard Scott | President & CEO | Award / Grant | 89,000 | — | — | Feb 20, 2025 |
| Knight Jeff E. | Chief Operating Officer | Award / Grant | 43,000 | — | — | Feb 20, 2025 |
| Pizzuti Dana | Chief Med and Dev Officer | Award / Grant | 43,000 | — | — | Feb 20, 2025 |
| Betz Stephen F. | Chief Scientific Officer | Award / Grant | 43,000 | — | — | Feb 20, 2025 |
| Pizzuti Dana | Chief Med and Dev Officer | Sale | 5,000 | $39.07 | $195,350 | Feb 3, 2025 |
| Pizzuti Dana | Chief Med and Dev Officer | Option Exercise | 2,500 | $19.64 | $49,100 | Jan 3, 2025 |
| Betz Stephen F. | Chief Scientific Officer | Option Exercise | 2,331 | $1.91 | $4,452 | Dec 16, 2024 |
| Struthers Richard Scott | President & CEO | Sale | 10,000 | $57.57 | $575,700 | Dec 2, 2024 |
| Knight Jeff E. | Chief Operating Officer | Sale | 501 | $56.52 | $28,317 | Nov 22, 2024 |
| Betz Stephen F. | Chief Scientific Officer | Other | 451 | $14.98 | $6,756 | Nov 20, 2024 |
| Wilson Marc | CFO | Other | 473 | $14.98 | $7,086 | Nov 20, 2024 |
| Pizzuti Dana | Chief Med and Dev Officer | Sale | 14,375 | $54.63 | $785,306 | Oct 3, 2024 |
| Wilson Marc | CFO | Option Exercise | 25,000 | $15.29 | $382,250 | Sep 26, 2024 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 1,035 | $51.50 | $53,303 | Sep 10, 2024 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,000 | $53.19 | $159,570 | Aug 26, 2024 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,000 | $47.68 | $143,040 | Aug 12, 2024 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,000 | $53.43 | $160,290 | Jul 25, 2024 |
| Wilson Marc | CFO | Sale | 19,056 | $53.88 | $1,026,737 | Jul 25, 2024 |
| Knight Jeff E. | Chief Operating Officer | Option Exercise | 5,687 | $19.64 | $111,693 | Jul 15, 2024 |
| Wilson Marc | CFO | Sale | 25,000 | $55.00 | $1,375,000 | Jul 15, 2024 |
| Betz Stephen F. | Chief Scientific Officer | Sale | 3,000 | $48.55 | $145,650 | Jul 10, 2024 |
| Hassard James | Chief Commercial Officer | Sale | 15,000 | $44.08 | $661,200 | Jul 5, 2024 |
| Pizzuti Dana | Chief Med and Dev Officer | Option Exercise | 14,375 | $16.89 | $242,794 | Jul 3, 2024 |
| Wilson Marc | CFO | Option Exercise | 32,129 | $9.28 | $298,157 | Jun 28, 2024 |
| Knight Jeff E. | Chief Operating Officer | Sale | 956 | $44.38 | $42,427 | Jun 26, 2024 |